Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer

被引:17
作者
Liu, Jianyu [1 ]
Wang, Xueying [1 ]
Deng, Yuhan [1 ]
Yu, Xin [1 ]
Wang, Hongbin [1 ]
Li, Zhigao [1 ]
机构
[1] Harbin Med Univ, Dept Surg Oncol, Canc Hosp, Harbin, Peoples R China
基金
中国国家自然科学基金;
关键词
regulatory T cell; tumor microenvironment; breast cancer; immunotherapy; neoadjuvant treatment; PATHOLOGICAL COMPLETE RESPONSE; INFILTRATING LYMPHOCYTES; TGF-BETA; NEOADJUVANT CHEMOTHERAPY; FOXP3; EXPRESSION; SELF-TOLERANCE; IN-VITRO; ANTITUMOR IMMUNITY; PERIPHERAL-BLOOD; DENDRITIC CELLS;
D O I
10.3389/fonc.2021.766248
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor microenvironment (TME) is a complex ecosystem comprised of cancer cells, stromal cells, and immune cells. Analysis of the composition of TME is essential to assess the prognosis of patients with breast cancer (BC) and the efficacy of different regimes. Treg plays a crucial role in the microenvironment of breast cancer subtypes, and its function contributes to the development and progression of BC by suppressing anti-tumor immunity directly or indirectly through multiple mechanisms. In addition, conventional treatments, such as anthracycline-based neoadjuvant chemotherapy, and neo-therapies, such as immune-checkpoint blockades, have a significant impact on the absence of Tregs in BC TME, thus gaining additional anti-tumor effect to some extent. Strikingly, Treg in BC TME revealed the predicted efficacy of some therapeutic strategies. All these results suggest that we can manipulate the abundance of Treg to achieve the ultimate effect of both conventional and novel treatments. In this review, we discuss new insights into the characteristics of Treg in BC TME, the impact of different regiments on Treg, and the possibilities of Treg as a predictive marker of efficacy for certain treatments.
引用
收藏
页数:16
相关论文
共 203 条
[1]   Natural and induced T regulatory cells in cancer [J].
Adeegbe, Dennis O. ;
Nishikawa, Hiroyoshi .
FRONTIERS IN IMMUNOLOGY, 2013, 4
[2]   To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity [J].
Ameratunga, Malaka ;
Kipps, Emma ;
Okines, Alicia F. C. ;
Lopez, Juanita S. .
CLINICAL CANCER RESEARCH, 2019, 25 (01) :21-28
[3]   The Prognostic Contribution of Clinical Breast Cancer Subtype, Age, and Race Among Patients With Breast Cancer Brain Metastases [J].
Anders, Carey K. ;
Deal, Allison M. ;
Miller, C. Ryan ;
Khorram, Carmen ;
Meng, Hong ;
Burrows, Emily ;
Livasy, Chad ;
Fritchie, Karen ;
Ewend, Matthew G. ;
Perou, Charles M. ;
Carey, Lisa A. .
CANCER, 2011, 117 (08) :1602-1611
[4]  
[Anonymous], 1703, BREAST CANC TRIALS
[5]   In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[6]  
Askolskyi A., 2018, ANN ONCOL, V29, pVIII87, DOI [10.1093/annonc/mdy271.267, DOI 10.1093/ANNONC/MDY271.267]
[7]   The hallmarks of CAFs in cancer invasion [J].
Attieh, Youmna ;
Vignjevic, Danijela Matic .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2016, 95 (11) :493-502
[8]   Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment [J].
Azizi, Elham ;
Carr, Ambrose J. ;
Plitas, George ;
Cornish, Andrew E. ;
Konopacki, Catherine ;
Prabhakaran, Sandhya ;
Nainys, Juozas ;
Wu, Kenmin ;
Kiseliovas, Vaidotas ;
Setty, Manu ;
Choi, Kristy ;
Fromme, Rachel M. ;
Phuong Dao ;
McKenney, Peter T. ;
Wasti, Ruby C. ;
Kadaveru, Krishna ;
Mazutis, Linas ;
Rudensky, Alexander Y. ;
Pe'er, Dana .
CELL, 2018, 174 (05) :1293-+
[9]   MHC class II expression identifies functionally distinct human regulatory T cells [J].
Baecher-Allan, Clare ;
Wolf, Elizabeth ;
Haller, David A. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :4622-4631
[10]   CCR8+FOXp3+ Treg cells as master drivers of immune regulation [J].
Barsheshet, Yiftah ;
Wildbaum, Gizi ;
Levy, Eran ;
Vitenshtein, Alon ;
Akinseye, Chika ;
Griggs, Jeremy ;
Lira, Sergio A. ;
Karin, Nathan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (23) :6086-6091